PHR1101 - Bridge to Practice II - 2019

6 points, SCA Band 2, 0.125 EFTSL

- Unit

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.


Pharmacy and Pharmaceutical Sciences

Chief examiner(s)

Dr Nilushi Karunaratne


Dr Nilushi Karunaratne

Unit guides



  • First semester 2019 (On-campus)


  • A completed relevant undergraduate degree with a minimum of a distinction average as part of the graduate entry pathway; and
  • PHR1001 Bridge to Practice I


  • PHR3041 Comprehensive Care: Blood, Brain & Cancers
  • PHR3141 Comprehensive Care: Pathogens, Host Defense, & Treatment


This unit is only available for applicants entering the Bachelor of Pharmacy (Honours) or Bachelor of Pharmacy (Honours)/ Masters of Pharmacy degrees through the graduate entry pathway. A previous relevant degree and certain criteria including pre-requisites and a distinction average is required for the pathway. This unit is available upon successful completion of the summer school unit PHR1001 as an overload unit.


This unit will focus on the management of selected cardiovascular, renal and endocrine conditions by relating the pathophysiology and clinical use of medicines and the development of a patient-specific care plan. This unit also introduces the concepts and applications of evidence-based practice, key components of medication safety and review and a systems-based approach to healthcare with respect to patients with complex needs. This unit will highlight the applications of pharmacokinetic and pharmacodynamic principles in the practice of pharmacy.


  1. Describe the signs and symptoms, diagnostic and epidemiological aspects of selected cardiovascular, endocrine and renal conditions.
  2. List and prioritise pharmacological and non-drug therapy options for the management of selected cardiovascular, endocrine and renal conditions.
  3. Evaluate a patient's cardiovascular, endocrine or renal condition and create a complete, patient-specific care plan that applies established clinical guidelines and a comprehensive review of potential medicationrelated problems.

  4. Apply counselling strategies that optimise therapy outcomes including behavioural change for patients in the management of selected cardiovascular, renal and endocrine conditions including when referral for medical assessment is required in selected cardiovascular, endocrine and renal conditions.
  5. Define and calculate drug bioavailability, clearance and volume of distribution and describe how these parameters relate to the plasma concentration profile of a drug.
  6. Describe different types of drug-drug interactions and predict their impact on plasma drug concentration vs time profiles and therapeutic response.
  7. Describe, calculate and apply a range of pharmacokinetic parameters that determine dosage regimens and explain how the relationship between pharmacokinetics and pharmacodynamics determines the time-course of drug response.

  8. Define, incorporate, interpret and apply a standardised approach to patient-centred care.
  9. Interpret, retrieve, appraise and apply evidence-based practice.
  10. Explain the key components of medication safety and policy documents, in the context of a pharmacist and a systems-based approach to healthcare.
  11. Reflect on identified strengths and weaknesses in communication and other non-cognitive skills via a Personalised Learning Plan to enhance professional skills required to practice as a pharmacist.


In-semester assessments 40%; End of semester assessment 60%

Workload requirements

Workload requirements include online modules and face to face interactive lectures and workshops which require compulsory attendance.

Contact hours for on-campus activities will include:

(+) Approximately 24 hours/week of interactive lectures and apply workshops

(+) Approximately 24 hours/week of independent study will be required

See also Unit timetable information

Additional information on this unit is available from the faculty at: